Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits.

BMC cancer - 8 May 2021

Wang Biyuan, Wang Hui, Zhao Andi, Zhang Mi, Yang Jin

Abstract excerpt

BACKGROUND: The purpose of this study was to explore clinicalpathology features, molecular features and outcome of male breast cancer patients who expressed ER, PR as well as HER-2, namely triple-positive male breast cancer (TP-MBC), and compared them with triple-positive female breast cancer patients (TP-FBC). METHODS: TP-MBC and TP-FBC from 2010 to 2017 were selected from the Surveillance, Epidemiology, and End...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms, Male
Share to Neoplasm Staging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Share to Propensity Score

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Share to SEER Program

Source

Open in PubMed Open full text

Identifiers

PMID: 33964913
DOI: 10.1186/s12885-021-08267-9
PMCID: PMC8106220

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits.PMID 33964913Read ↗

A 64-Year-Old Man With Germline BRCA2-Mutated Breast Cancer: Known and Unknown Aspects of Male Breast Cancer.Semantic proximity Read ↗

Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancer.Semantic proximity Read ↗

Male Breast Cancer (MBC) - A Review.Semantic proximity Read ↗

Male Breast Cancer in the Age of Genetic Testing: An Opportunity for Early Detection, Tailored Therapy, and Surveillance.Semantic proximity Read ↗

Male breast cancer: a rare disease that might uncover underlying pathways of breast cancer.Semantic proximity Read ↗

New Biomarkers and Treatment Advances in Triple-Negative Breast CancerSemantic proximity Read ↗

Male breast cancer.Semantic proximity Read ↗

Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis.Semantic proximity Read ↗

Divide and Conquer—Targeted Therapy for Triple-Negative Breast CancerSemantic proximity Read ↗

The cancer genetics and pathology of male breast cancer.Semantic proximity Read ↗

An updated review of epidemiology, risk factors, and management of male breast cancer.Semantic proximity Read ↗

Characterisation of male breast cancer: a descriptive biomarker study from a large patient series.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.